Refine Results
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2610)
  2. Meeting Abstract (2246)
  3. Review (79)
  4. Book Section (62)
  5. Editorial (55)
  6. Research Letter (18)
  7. Conference Paper (8)
  8. Guidelines (8)
  9. Correspondence (6)
  10. Miscellaneous (6)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5101)
  2. GSK Faculty (4398)
  3. Department of Medicine (3105)
  4. Solid Tumor Oncology Division (2007)
  5. Sloan Kettering Institute Postdocs (1523)
  6. Hematologic Malignancies, Division of (1360)

More Groups

People
  1. Marc Ladanyi (1179)
  2. David Solit (653)
  3. Ross Levine (633)
  4. Michael Berger (594)
  5. Jorge Reis-Filho (504)
  6. Omar Abdel-Wahab (438)

More People

Years
  1. 2022 (137)
  2. 2021 (362)
  3. 2020 (468)
  4. 2019 (464)
  5. 2018 (426)
  6. 2017 (366)

More Years

Publications
  1. Journal of Clinical Oncology (455)
  2. Cancer Research (450)
  3. Modern Pathology (387)
  4. Blood (349)
  5. Laboratory Investigation (329)
  6. Clinical Cancer Research (243)

More Publications

Publishers
  1. American Association for Cancer Research (859)
  2. Nature Publishing Group (752)
  3. American Society of Clinical Oncology (493)
  4. Nature Research (397)
  5. American Society of Hematology (367)
  6. Elsevier Inc. (291)

More Publishers

Results (5101)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting mTOR and MEK or ERK inhibits the growth of PDX models of NF1-deficient pediatric sarcoma
    Meeting Abstract

    Lu, Y. C.; Odintsov, I.; Khodos, I.; Mattar, M.; Glade Bender, J.; Wexler, L.; de Stanchina, E.; Ladanyi, M.; Somwar, R.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Mato, A.; Pagel, J.; Coombs, C.; Shah, N.; Lamanna, N.; Munir, T.; Lech-Maranda, E.; Eyre, T.; Woyach, J.; Wierda, W.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Determining PD-L1 status in patients with triple-negative breast cancer: Lessons learned from IMpassion130
    Review

    Badve, S. S.; Penault-Llorca, F.; Reis-Filho, J. S.; Deurloo, R.; Siziopikou, K. P.; D'Arrigo, C.; Viale, G.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors
    Journal Article

    Chi, P.; Qin, L.; Camacho, N.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues
    Journal Article

    Moukarzel, L. A.; Ferrando, L.; Dopeso, H.; Stylianou, A.; Basili, T.; Pareja, F.; Da Cruz Paula, A.; Zoppoli, G.; Abu-Rustum, N. R.; Reis-Filho, J. S.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
    Guidelines

    Shonka, D. C. Jr; Ho, A.; Chintakuntlawar, A. V.; Geiger, J. L.; Park, J. C.; Seetharamu, N.; Jasim, S.; Abdelhamid Ahmed, A. H.; Bible, K. C.; Brose, M. S.; more...
    Head & Neck (2022)

    Fulltext@MSK | Save
  • Computational methods and translational applications for targeted next-generation sequencing platforms
    Review

    Luthra, A.; Mastrogiacomo, B.; Smith, S. A.; Chakravarty, D.; Schultz, N.; Sanchez-Vega, F.
    Genes Chromosomes and Cancer (2022)

    Fulltext@MSK | Save
  • Granular cell tumor of thyroid: A case series with molecular characterization highlighting unique pitfalls
    Journal Article

    Srivastava, P.; Da Cruz Paula, A.; Weigelt, B.; Pareja, F.; Reis-Filho, J. S.; Yip, L.; Pantanowitz, L.; Seethala, R. R.
    Endocrine (2022)

    Fulltext@MSK | Save
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Evidence for reduced BRCA2 functional activity in Homo sapiens after divergence from the chimpanzee-human last common ancestor
    Journal Article

    Huang, J.; Zhong, Y.; Makohon-Moore, A. P.; White, T.; Jasin, M.; Norell, M. A.; Wheeler, W. C.; Iacobuzio-Donahue, C. A.
    Cell Reports (2022)

    Fulltext@MSK | Save